Clincosm LogoSign in Get a demo

Value For Veterans (V4V)

Sponsor
VA Ann Arbor Healthcare System (U.S. Fed)
Overall Status
Recruiting
CT.gov ID
NCT05026684
Collaborator
VA Center for Clinical Management Research (Other)
150
Enrollment
1
Location
1
Arm
11.5
Anticipated Duration (Months)
13
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The COVID-19 pandemic has transformed the delivery of ambulatory care in the US. One of the most notable changes to ambulatory care practice has been the rapid expansion of telemedicine services. Such expansion sought to preserve access to necessary care for patients while protecting them and their clinicians from undue risk of exposure to COVID-19.

This multiphase, Veteran-centered approach to developing and evaluating a novel behavioral intervention to provide full cost transparency to Veterans will achieve the following aims:

Aim 1: Create an automated system to generate personalized estimates of Veterans' full costs (travel costs, time costs, and out-of-pocket costs) for different types of primary care visits.

Aim 2: Develop and refine a novel behavioral intervention that will help Veterans and their clinicians use personalized information about the full costs of different types of primary care visits in the VHA.

Aim 3: Evaluate the acceptability, feasibility, and preliminary effectiveness of the developed intervention to Veterans and their clinicians.

Condition or Disease Intervention/Treatment Phase
  • Other: Personalized cost handout
 N/A

Detailed Description

Within VA Primary Care, the COVID-19 pandemic has resulted in an abrupt shift from mostly face-to-face visits to almost exclusively telephone and VA Video Connect (VVC) appointments. As the COVID-19 curve has flattened and personal protective equipment (PPE) supplies have stabilized, VA Medical Centers such as the VA Ann Arbor Healthcare System are now grappling with how to match these opportunities for different vehicles for delivering ambulatory care to patients' needs and preferences. One highly promising, Veteran-centered way to match opportunities for face-to-face, telephone, and VVC visits in the COVID-19 era is to consider the value each visit type yields for an individual Veteran. Value for a given health care service is broadly defined as its health outcomes (i.e., benefits) per dollars spent (i.e., costs). From the perspective of patients, costs entail not just out-of-pocket (OOP) expenses but also travel and time costs. These costs are even more salient for many Veterans in the current economic downturn which, unfortunately, is unlikely to abate until the US fully emerges from the COVID-19 pandemic. Careful consideration of these full costs -- which can vary widely across face-to-face, telephone, and VVC visits -- by both Veterans and their clinicians could result in higher-value ambulatory care visits. For example, when services could be provided by telephone rather than a face-to-face visit, the former would result in much higher value for Veterans because there are no copays or travel costs for telephone visits. Similarly, when a face-to-face visit is necessary, transparent cost information could encourage Veterans and their clinicians to maximize the necessary services delivered, amplifying the benefits realized for the relatively higher patient cost of that particular type of visit.

Despite the clear benefits of making patient costs more transparent, and of broader policy initiatives within VA to better inform Veterans' health care choices, Veterans and their clinicians currently lack the personalized cost information that they need to make high-value choices about ambulatory visit modalities. This project will make transparent the full costs to Veterans of different types of ambulatory visits in order to optimize the value of their health care investments in the COVID-19 era and beyond.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
150 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Achieving Greater Value for Veterans Through Full Cost Transparency
Actual Study Start Date :
Jul 15, 2021
Anticipated Primary Completion Date :
May 30, 2022
Anticipated Study Completion Date :
Jun 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Experimental group

Personalized cost information group.

Other: Personalized cost handout
Patients will be given a personalized cost handout to make transparent the full costs to Veterans of different types of ambulatory visits in order to optimize the value of their health care investments.

Outcome Measures

Primary Outcome Measures

  1. Level of confidence in understanding costs of different visit type options [Within one week of appointment]

    Measured by telephone survey

Secondary Outcome Measures

  1. Conversations about different visit type options [Within one week of appointment]

    Measured by telephone survey

  2. Perceived helpfulness of intervention [Within one week of appointment]

    Measured by telephone survey

  3. Interest in receiving information in future [Within one week of appointment]

    Measured by telephone survey

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age 18 years or older with an upcoming face-to-face, telephone, or VVC appointment with a consenting Primary Care provider at the Ann Arbor VA.
Exclusion Criteria:

  • Under the age of 18.

  • Mild cognitive impairment, dementia, psychotic disorder, or unable to provide informed consent.

Contacts and Locations

Locations

Site City State Country Postal Code
1 VA Ann Arbor Healthcare System Ann Arbor Michigan United States 48105

Sponsors and Collaborators

  • VA Ann Arbor Healthcare System
  • VA Center for Clinical Management Research

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
VA Ann Arbor Healthcare System
ClinicalTrials.gov Identifier:
NCT05026684
Other Study ID Numbers:
  • VAAnnArbor
First Posted:
Aug 30, 2021
Last Update Posted:
Apr 29, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by VA Ann Arbor Healthcare System
Cost
Value
Veterans
Behavioral Intervention
Personalized healthcare

Study Results

No Results Posted as of Apr 29, 2022